Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)"

Cabrera-Perez, Javier S; Eigenmann, Philippe; Akenroye, Ayobami

doi:10.1111/pai.14128

Scientific article

Editorial

English

Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)"

ContributorsCabrera-Perez, Javier S; Eigenmann, Philippe

; Akenroye, Ayobami

Published inPediatric allergy and immunology, vol. 35, no. 4, e14128

Publication date2024-04

Abstract

Editorial comment on : Wedner HJ, Fujisawa T, Guilbert TW, Ikeda M, Mehta V, Tam JS, Lukka PB, Asimus S, Durżyński T, Johnston J, White WI, Shah M, Werkström V, Jison ML; all TATE investigators. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study). Pediatr Allergy Immunol. 2024 Mar;35(3):e14092. doi: 10.1111/pai.14092. PMID: 38491795.

Keywords

Humans
Asthma / drug therapy
Anti-Asthmatic Agents / therapeutic use
Anti-Asthmatic Agents / pharmacokinetics
Child
Antibodies, Monoclonal, Humanized / pharmacokinetics
Antibodies, Monoclonal, Humanized / therapeutic use
Antibodies, Monoclonal, Humanized / adverse effects
Eosinophilia
Eosinophils / immunology
Severity of Illness Index
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Research groups

Pathogenèse et traitement des allergies alimentaires (191)

Citation (ISO format)

CABRERA-PEREZ, Javier S, EIGENMANN, Philippe, AKENROYE, Ayobami. Editorial comment on ‘Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)’. In: Pediatric allergy and immunology, 2024, vol. 35, n° 4, p. e14128. doi: 10.1111/pai.14128

Article (Published version)

Identifiers

PID : unige:188102
DOI : 10.1111/pai.14128
PMID : 38646955

Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/10.1111/pai.14128

Journal ISSN0905-6157

11views

0downloads

Creation26/09/2025 10:48:38

First validation06/10/2025 09:33:19

Update time06/10/2025 12:23:45

Status update06/10/2025 12:23:45

Last indexation06/10/2025 12:24:07

Archive ouverte UNIGE

Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)"

Technical informations